Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

09:29
11/23/16
11/23
09:29
11/23/16
09:29

Eli Lilly falls sharply after solanezumab trial did not meet endpoint

The stock was last down over 15.6% to $63.99 to a new 52-week low. At that price $62.19 is next support. Resistance is at $65.54.

  • 04

    Dec

LLY Eli Lilly

11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.
11/23/16
JPMS
11/23/16
NO CHANGE
Target $85
JPMS
Overweight
JPMorgan sees 'attractive opportunity' amid Eli Lilly selloff
JPMorgan analyst Chris Schott lowered his price target for Eli Lilly to $85 from $95 after the phase III trial of solanezumab missed on both primary and secondary endpoints. Beyond solanezumab, Lilly has a diverse range of new product opportunities that support 5% sales and mid-teens earnings growth, Schott tells investors in a research note. With the shares down 13% to $65.81 in pre-market trading, the analyst sees an "attractive opportunity." He keeps an Overweight rating on Lilly.
11/23/16
JEFF
11/23/16
NO CHANGE
Target $100
JEFF
Buy
Eli Lilly still expects to grow revenue, says Jefferies
Jefferies analyst Jeffrey Holford says that while the solanezumab Phase III trial failure is disappointing, Eli Lilly management expects to grow revenue between 2015 and 2020 while expanding margins. Further, the company is still pursuing the Alzheimer's indication though a number of other programs, Holford tells investors in a research note. The analyst previously estimated a negative solanezumab trial outcome could see the stock down $12. Shares of Lilly are currently down $10.19 to $65.80 in pre-market trading. Holford keeps a Buy rating on Lilly with a $100 price target.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.

TODAY'S FREE FLY STORIES

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

16:47
06/27/17
06/27
16:47
06/27/17
16:47
Hot Stocks
Global Medical REIT provides update on acquisition of cardiac clinic in Lubbok »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:46
06/27/17
06/27
16:46
06/27/17
16:46
Hot Stocks
Ryerson comments on Q2 market conditions, demand environment »

In a press release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:43
06/27/17
06/27
16:43
06/27/17
16:43
Earnings
Ryerson sees Q2 net income $0M-$2M »

EPS consensus 35c. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
06/27/17
06/27
16:38
06/27/17
16:38
General news
API crude inventories for week of June 23 »

API reports that crude…

SSTK

Shutterstock

$43.81

-0.94 (-2.10%)

16:37
06/27/17
06/27
16:37
06/27/17
16:37
Hot Stocks
Shutterstock to acquire Flashstock for approximately $50M cash »

Shutterstock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$77.77

0.26 (0.34%)

16:36
06/27/17
06/27
16:36
06/27/17
16:36
Hot Stocks
Aflac recommends shareholders to reject mini-tender offer by TRC Capital »

Aflac announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$36.97

0.13 (0.35%)

, BA

Boeing

$198.89

-1.09 (-0.55%)

16:34
06/27/17
06/27
16:34
06/27/17
16:34
Hot Stocks
Air Lease delivers Boeing 737-800 to Travel Service »

Air Lease Corporation…

AL

Air Lease

$36.97

0.13 (0.35%)

BA

Boeing

$198.89

-1.09 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CEMI

Chembio Diagnostics

16:33
06/27/17
06/27
16:33
06/27/17
16:33
Syndicate
Chembio establishes "at-the-market" program »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

OC

Owens Corning

$66.05

-0.65 (-0.97%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Owens Corning completes acquisition of Pittsburgh Corning for $560M »

Owens Corning announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLLS

Cellectis

$24.34

-0.69 (-2.76%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Cellectis announces first in human administration in AML study »

Cellectis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NSAT

Norsat

$11.50

0.1 (0.88%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Norsat receives court approval for arrangement with Hytera Communications »

Norsat International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$4.85

0.01 (0.21%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Meet Group reaches agreement with Harvest Capital »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/27/17
06/27
16:30
06/27/17
16:30
Options
Preliminary option volume of 15.8M today »

Preliminary option volume…

16:25
06/27/17
06/27
16:25
06/27/17
16:25
Conference/Events
CFA Society of North Carolina to hold a panel discussion »

The CFA Society of North…

CVS

CVS Health

$80.49

0.37 (0.46%)

16:20
06/27/17
06/27
16:20
06/27/17
16:20
Initiation
CVS Health initiated  »

CVS Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
Initiation
Walgreens Boots Alliance initiated  »

Walgreens Boots Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

S

Sprint

$8.18

0.17 (2.12%)

, TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
General news
On The Fly: Top stock stories for Tuesday »

Stocks moved in a very…

S

Sprint

$8.18

0.17 (2.12%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

CMCSA

Comcast

$39.25

-0.34 (-0.86%)

CHTR

Charter

$329.87

-2.78 (-0.84%)

VZ

Verizon

$44.84

-0.91 (-1.99%)

T

AT&T

$37.70

-0.45 (-1.18%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

MRK

Merck

$65.54

-0.38 (-0.58%)

MDLZ

Mondelez

$43.97

-0.93 (-2.07%)

WPPGY

WPP PLC

$104.96

-0.97 (-0.92%)

FDX

FedEx

$214.39

-0.97 (-0.45%)

CBI

CB&I

$20.02

5.62 (39.03%)

DRI

Darden

$92.69

2.61 (2.90%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

STX

Seagate

$39.51

-2.88 (-6.79%)

RARX

RA Pharmaceuticals

$17.69

-4.49 (-20.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 07

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 21

    Sep

  • 22

    Sep

CEMI

Chembio Diagnostics

16:18
06/27/17
06/27
16:18
06/27/17
16:18
Syndicate
Breaking Syndicate news story on Chembio Diagnostics »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

$NSD

NASDAQ Market Internals

16:17
06/27/17
06/27
16:17
06/27/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$23.32

-0.61 (-2.55%)

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Initiation
Square initiated  »

Square assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

$NYE

NYSE Market Internals

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$52.73

-1.01 (-1.88%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
PayPal initiated  »

PayPal assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

CFI

Culp

$32.25

-0.25 (-0.77%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Hot Stocks
Culp changes NYSE ticker symbol to 'CULP' »

Culp, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAWK

Blackhawk

$41.90

-1.1 (-2.56%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
Blackhawk initiated  »

Blackhawk initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$109.76

-1.25 (-1.13%)

16:14
06/27/17
06/27
16:14
06/27/17
16:14
Hot Stocks
UPS to freeze retirement plan benefits for non-union employees »

United Parcel Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.